{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T04:24:00Z","timestamp":1783571040491,"version":"3.55.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.4158\/ep-2019-0396","type":"journal-article","created":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T14:08:48Z","timestamp":1581430128000},"page":"514-522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["ProGRP as a Novel Biomarker for the Differential Diagnosis of Medullary Thyroid Carcinoma in Patients with Thyroid Nodules"],"prefix":"10.1016","volume":"26","author":[{"given":"Xianming","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjing","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huipin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ende","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoyang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP-2019-0396_bb0010","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid"},{"key":"10.4158\/EP-2019-0396_bb0015","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1507\/endocrj.EJ17-0238","article-title":"Fine-needle aspiration cytology for medullary thyroid carcinoma: a single institutional experience in Japan","volume":"64","author":"Suzuki","year":"2017","journal-title":"Endocr J"},{"key":"10.4158\/EP-2019-0396_bb0020","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2303.2010.00747.x","article-title":"Fine needle aspiration cytology of medullary carcinoma of the thyroid with a focus on rare variants: a review of 78 cases","volume":"22","author":"Kaushal","year":"2011","journal-title":"Cytopathology"},{"key":"10.4158\/EP-2019-0396_bb0025","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1159\/000326191","article-title":"Medullary thyroid carcinoma: pitfalls in diagnosis by fine needle aspiration cytology and relationship of cytomorphology to RET proto-oncogene mutations","volume":"49","author":"Chang","year":"2005","journal-title":"Acta Cytol"},{"key":"10.4158\/EP-2019-0396_bb0030","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1515\/cclm-2015-0058","article-title":"Serum calcitonin negative medullary thyroid carcinoma: a systematic review of the literature","volume":"53","author":"Trimboli","year":"2015","journal-title":"Clin Chem Lab Med"},{"key":"10.4158\/EP-2019-0396_bb0035","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1515\/cclm-2016-0572","article-title":"Utility of proGRP as a tumor marker in the medullary thyroid carcinoma","volume":"55","author":"Parra-Robert","year":"2017","journal-title":"Clin Chem Lab Med"},{"key":"10.4158\/EP-2019-0396_bb0040","first-page":"231","article-title":"Pro-gastrin-releasing peptide (ProGRP) as a biomarker in small-cell lung cancer diagnosis, monitoring and evaluation of treatment response","volume":"8","author":"Wojcik","year":"2017","journal-title":"Lung Cancer"},{"key":"10.4158\/EP-2019-0396_bb0045","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1111\/jcmm.13722","article-title":"Diagnostic and therapeutic value of progastrin-releasing peptide on small-cell lung cancer: a single-center experience in China","volume":"22","author":"Wu","year":"2018","journal-title":"J Cell Mol Med"},{"key":"10.4158\/EP-2019-0396_bb0050","first-page":"4219","article-title":"Serum ProGRP and NSE levels predicting small cell lung cancer transformation in a patient with ALK rearrangement-positive non-small cell lung cancer: a case report","volume":"16","author":"Oya","year":"2018","journal-title":"Oncol Lett"},{"key":"10.4158\/EP-2019-0396_bb0055","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2220\/biomedres.36.273","article-title":"ProGRP is a possible tumor marker for patients with Ewing sarcoma","volume":"36","author":"Yamaguchi","year":"2015","journal-title":"Biomed Res"},{"key":"10.4158\/EP-2019-0396_bb0060","first-page":"669","article-title":"Biomarkers of neuroendocrine tumors","volume":"74","author":"d'Herbomez","year":"2016","journal-title":"Ann Biol Clin"},{"key":"10.4158\/EP-2019-0396_bb0065","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0090-4295(02)01774-0","article-title":"Serum pro-gastrin-releasing peptide (31\u201398) in benign prostatic hyperplasia and prostatic carcinoma","volume":"60","author":"Nagakawa","year":"2002","journal-title":"Urology"},{"key":"10.4158\/EP-2019-0396_bb0070","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000012148","article-title":"Demonstration and diagnostic significance of pro-gastrin-releasing peptide in medullary thyroid carcinoma","volume":"59","author":"Inaji","year":"2000","journal-title":"Oncology"},{"key":"10.4158\/EP-2019-0396_bb0075","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.7754\/Clin.Lab.2018.180316","article-title":"Clinical application of pro-gastrin-releasing peptide","volume":"64","author":"Fang","year":"2018","journal-title":"Clin Lab"},{"key":"10.4158\/EP-2019-0396_bb0080","first-page":"391","article-title":"Meta-analysis of serum gastrin-releasing peptide precursor as a biomarker for diagnosis of small cell lung cancer","volume":"18","author":"Lv Sh","year":"2017","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.4158\/EP-2019-0396_bb0085","first-page":"527","article-title":"Utility of ProGRP determinations in cancer patients","volume":"56","author":"Wojcik","year":"2010","journal-title":"Clin Lab"},{"key":"10.4158\/EP-2019-0396_bb0090","article-title":"Expression and clinical value of gastrin-releasing peptide precursor in nephropathy and chronic kidney disease","author":"Dai","year":"2019","journal-title":"Nephrology."},{"key":"10.4158\/EP-2019-0396_bb0095","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"key":"10.4158\/EP-2019-0396_bb0100","doi-asserted-by":"crossref","first-page":"920","DOI":"10.4158\/EP13143.OR","article-title":"Fine needle aspiration and medullary thyroid carcinoma: the risk of inadequate preoperative evaluation and initial surgery when relying upon FNAB cytology alone","volume":"19","author":"Essig","year":"2013","journal-title":"Endocr Pract"},{"key":"10.4158\/EP-2019-0396_bb0105","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.lungcan.2013.06.003","article-title":"Transformation to small-cell lung cancer following treatment with EGFR tyrosine kinase inhibitors in a patient with lung adenocarcinoma","volume":"82","author":"Watanabe","year":"2013","journal-title":"Lung Cancer"},{"key":"10.4158\/EP-2019-0396_bb0110","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1515\/cclm-2016-0543","article-title":"Measurement of thyroglobulin, calcitonin, and PTH in FNA washout fluids","volume":"55","author":"Trimboli","year":"2017","journal-title":"Clin Chem Lab Med"},{"key":"10.4158\/EP-2019-0396_bb0115","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/jama.2018.0898","article-title":"The diagnosis and management of thyroid nodules: a review","volume":"319","author":"Durante","year":"2018","journal-title":"JAMA"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X2035028X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X2035028X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:08:03Z","timestamp":1761516483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X2035028X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S1530891X2035028X"],"URL":"https:\/\/doi.org\/10.4158\/ep-2019-0396","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ProGRP as a Novel Biomarker for the Differential Diagnosis of Medullary Thyroid Carcinoma in Patients with Thyroid Nodules","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP-2019-0396","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}